November 1, 2019

Antony Koblish
President and Chief Executive Officer
TELA Bio, Inc.
1 Great Valley Parkway, Suite 24
Malvern, Pennsylvania 19355

       Re: TELA Bio, Inc.
           Amendment No. 1 to Registration Statement on Form S-1
           Filed October 29, 2019
           File No. 333-234217

Dear Mr. Koblish:

      We have reviewed your amended registration statement and have the
following
comments. In some of our comments, we may ask you to provide us with
information so we
may better understand your disclosure.

       Please respond to this letter by amending your registration statement
and providing the
requested information. If you do not believe our comments apply to your facts
and
circumstances or do not believe an amendment is appropriate, please tell us why
in your
response.

       After reviewing any amendment to your registration statement and the
information you
provide in response to these comments, we may have additional comments.

Amendment No. 1 to Registration Statement on Form S-1 filed October 29, 2019

Our fourth amended and restated certificate of incorporation . . ., page 57

1.     We note the disclosure here that the provision cited in this risk factor
does not apply to
       actions arising under the Securities Act or Exchange Act; however, the
articles of
       incorporation and bylaws filed with this amendment do not include a
similar statement.
       As such, if true, please amend your articles and bylaws to state that
this provision does not
       apply to actions arising under the Securities Act or Exchange Act.
Alternatively, please
       tell us how you intend to make investors aware of the provision's
limited applicability.
       For example, will you include disclosure in your future Exchange Act
reports?
       You may contact Tara Harkins at 202-551-3639 or Lynn Dicker, Senior
Accountant, at
202-551-3616 if you have questions regarding comments on the financial
statements and related
matters. Please contact Thomas Jones at 202-551-3602 or Geoffrey Kruczek,
Senior Attorney, at
 Antony Koblish
TELA Bio, Inc.
November 1, 2019
Page 2

202-551-3641 with any other questions.



                                         Sincerely,
FirstName LastNameAntony Koblish
                                         Division of Corporation Finance
Comapany NameTELA Bio, Inc.
                                         Office of Manufacturing
November 1, 2019 Page 2
cc:       Rachael M. Bushey
FirstName LastName